메뉴 건너뛰기




Volumn 306, Issue 3, 2011, Pages 312-314

Reducing the long-term effects of chemotherapy in young women with early-stage breast cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; ESTRADIOL; FLUOROURACIL; FOLLITROPIN; GONADORELIN AGONIST; GOSERELIN; METHOTREXATE; TAMOXIFEN; TAXANE DERIVATIVE; TRIPTORELIN;

EID: 79960474380     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1019     Document Type: Editorial
Times cited : (18)

References (17)
  • 1
    • 79952945610 scopus 로고    scopus 로고
    • Web site Accessed June, 2011
    • SEER Stat Fact Sheets: breast. Surveillance, Epidemiology and End Results Web site. http://seer.cancer.gov/statfacts/html/breast.html. Accessed June, 2011.
    • SEER Stat Fact Sheets: Breast
  • 4
    • 0029864362 scopus 로고    scopus 로고
    • Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer
    • Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14(5):1718-1729. (Pubitemid 26134232)
    • (1996) Journal of Clinical Oncology , vol.14 , Issue.5 , pp. 1718-1729
    • Bines, J.1    Oleske, D.M.2    Cobleigh, M.A.3
  • 5
    • 26444542783 scopus 로고    scopus 로고
    • Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane
    • Fornier MN, Modi S, Panageas KS, Norton L, Hudis C. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer. 2005;104(8):1575-1579.
    • (2005) Cancer , vol.104 , Issue.8 , pp. 1575-1579
    • Fornier, M.N.1    Modi, S.2    Panageas, K.S.3    Norton, L.4    Hudis, C.5
  • 6
    • 77953169551 scopus 로고    scopus 로고
    • Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer
    • Swain SM, Jeong JH, Geyer CE Jr, et al. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med. 2010;362(22):2053-2065.
    • (2010) N Engl J Med , vol.362 , Issue.22 , pp. 2053-2065
    • Swain, S.M.1    Jeong, J.H.2    Geyer Jr., C.E.3
  • 8
    • 79960552565 scopus 로고    scopus 로고
    • The prevalence of self-reported reproductive impairment in young female cancer survivors throughout California
    • abstract
    • Letourneau JM, Ebbel E, Katz P, Oktay K, et al. The prevalence of self-reported reproductive impairment in young female cancer survivors throughout California [abstract]. Fertil Steril. 2010;94(4):510.
    • (2010) Fertil Steril , vol.94 , Issue.4 , pp. 510
    • Letourneau, J.M.1    Ebbel, E.2    Katz, P.3    Oktay, K.4
  • 9
    • 77953697699 scopus 로고    scopus 로고
    • Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer
    • Partridge AH, Ruddy KJ, Gelber S, et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril. 2010;94(2):638-644.
    • (2010) Fertil Steril , vol.94 , Issue.2 , pp. 638-644
    • Partridge, A.H.1    Ruddy, K.J.2    Gelber, S.3
  • 10
    • 77955557956 scopus 로고    scopus 로고
    • Pharmacological interventions for fertility preservation during chemotherapy: A systematic review and meta-analysis
    • Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM. Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2010;122(3):803-811.
    • (2010) Breast Cancer Res Treat , vol.122 , Issue.3 , pp. 803-811
    • Ben-Aharon, I.1    Gafter-Gvili, A.2    Leibovici, L.3    Stemmer, S.M.4
  • 11
    • 79960545091 scopus 로고    scopus 로고
    • Effect of the gondadotropin-releasing hormone analogue triptorelin on the occurence of chemotherapy-induced early menopause in premenopausal women with breast cancer: A randomized trial
    • Del Mastro L, Boni L, Michelotto A, et al. Effect of the gondadotropin-releasing hormone analogue triptorelin on the occurence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA. 2011;306(3):269-276.
    • (2011) JAMA , vol.306 , Issue.3 , pp. 269-276
    • Del Mastro, L.1    Boni, L.2    Michelotto, A.3
  • 12
    • 61349159177 scopus 로고    scopus 로고
    • Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: Prospective randomized study
    • Badawy A, Elnashar A, El-Ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril. 2009;91(3):694-697.
    • (2009) Fertil Steril , vol.91 , Issue.3 , pp. 694-697
    • Badawy, A.1    Elnashar, A.2    El-Ashry, M.3    Shahat, M.4
  • 13
    • 70349573528 scopus 로고    scopus 로고
    • Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: Results from a randomized trial
    • Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat. 2009;117(3):561-567.
    • (2009) Breast Cancer Res Treat , vol.117 , Issue.3 , pp. 561-567
    • Sverrisdottir, A.1    Nystedt, M.2    Johansson, H.3    Fornander, T.4
  • 14
    • 79959195282 scopus 로고    scopus 로고
    • Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: The GBG 37 ZORO study
    • Gerber B, von Minckwitz G, Stehle H, et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol. 2011;29(17):2334-2341.
    • (2011) J Clin Oncol , vol.29 , Issue.17 , pp. 2334-2341
    • Gerber, B.1    Von Minckwitz, G.2    Stehle, H.3
  • 15
    • 67650415551 scopus 로고    scopus 로고
    • Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: A randomized trial using the GnRH agonist (triptorelin) during chemotherapy
    • abstract
    • Ismail-Kahn R, Minton S, Cox C, et al. Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: a randomized trial using the GnRH agonist (triptorelin) during chemotherapy [abstract]. J Clin Oncol. 2008(suppl):26.
    • (2008) J Clin Oncol , Issue.SUPPL. , pp. 26
    • Ismail-Kahn, R.1    Minton, S.2    Cox, C.3
  • 16
    • 79952005263 scopus 로고    scopus 로고
    • The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer
    • abstract
    • Leonard RC, Adamson D, Anderson R, et al. The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer [abstract]. J Clin Oncol. 2010;28(suppl):15S.
    • (2010) J Clin Oncol , vol.28 , Issue.SUPPL.
    • Leonard, R.C.1    Adamson, D.2    Anderson, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.